Company profile: Silk Road Medical
1.1 - Company Overview
Company description
- Provider of less-invasive medical devices and solutions for treating vascular diseases, specializing in carotid artery disease through proprietary trans-carotid therapies. Offers the TransCarotid Artery Revascularization (TCAR) procedure with reverse flow neuroprotection and a system that redirects blood away from the brain to capture debris before returning it to a leg vessel.
Products and services
- Proprietary Trans-Carotid Therapies: Delivers less-invasive trans-carotid treatment approaches that improve carotid artery disease care, facilitating carotid access and therapy with company-developed devices using a proprietary approach
- Reverse Flow & Neuroprotection System: Engineers a neuroprotective system used during TCAR to temporarily reverse blood flow away from the brain, capturing embolic debris, then returning blood to a leg vessel
- TransCarotid Artery Revascularization (TCAR): Architects a carotid artery revascularization procedure treating carotid artery disease by incorporating reverse flow neuroprotection to reduce stroke risk during intervention, minimally invasive
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Silk Road Medical
Bolt Medical
HQ: United States
Website
- Description: Provider of investigational medical devices for calcified arterial lesions, including Bolt IVLTM/Bolt IVL intravascular lithotripsy using laser-based acoustic pressure waves for coronary and peripheral arteries; RESTORE ATK/BTK systems for peripheral arterial disease above/below the knee; and the RESTORE FIH Coronary System, all under clinical evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bolt Medical company profile →
Celera
HQ: United States
Website
- Description: Provider of molecular diagnostic products and services that leverage knowledge of human variability to personalize disease management, enabling hospitals and clinical laboratories to detect, characterize, monitor, and select treatment for disease, including genotyping for infections diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celera company profile →
Nuubo
HQ: Spain
Website
- Description: Provider of wireless, wearable technologies for physiological monitoring via the nECG DYNAMIC PLATFORM to perform and read electrocardiograms remotely. Offerings include the Nuubo Textile Electrode for high-quality ECG during daily activities, a 30-day Nuubo Monitoring Report, Nuubo Device Installation guidance, the myNuubo app for symptom tracking and charge reminders, and scientific research in validation, risk stratification, arrhythmias, and cardiac rehabilitation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nuubo company profile →
TherOx
HQ: United States
Website
- Description: Provider of SuperSaturated Oxygen (SSO2) Therapy, a catheter-based treatment delivering hyperoxemic oxygen to the ischemic myocardium following PCI to reduce infarct size, and the TherOx DownStream System for preparation and delivery of SSO2 to targeted ischemic regions of the heart immediately after revascularization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TherOx company profile →
DeVoro Medical
HQ: United States
Website
- Description: Provider of thrombectomy medical devices to restore blood flow, including the WOLF Thrombectomy Platform that captures and removes blood clots from the arterial and venous systems using finger-like prongs, without the need for a console or lytic agents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DeVoro Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Silk Road Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Silk Road Medical
2.2 - Growth funds investing in similar companies to Silk Road Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Silk Road Medical
4.2 - Public trading comparable groups for Silk Road Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →